CCc1nn(CCCC(=O)N2CCN(c3cc(Cl)ccc3C)CC2)c(=O)c2cc3occc3n12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?